Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
07/14/20223:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Second Quarter 2022 Operating ResultsNASDAQ:IMGNImmunoGen Inc
07/05/20223:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/05/20223:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/05/20223:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/05/20223:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/05/20223:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/05/20223:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
06/17/20224:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/17/20223:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/17/20223:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/17/20223:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/17/20223:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/17/20223:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/17/20223:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/13/20225:30AMBusiness WireImmunoGen Announces Research Collaboration with Oxford BioTherapeutics to Develop Novel Antibody-Drug ConjugatesNASDAQ:IMGNImmunoGen Inc
06/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
05/27/202210:36PMTipRanksAnalysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Avadel Pharmaceuticals (AVDL) and ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
05/26/20224:00PMBusiness WireImmunoGen Presents Additional Efficacy and Safety Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ASCONASDAQ:IMGNImmunoGen Inc
05/25/20223:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
05/23/20229:05PMTipRanksAnalysts Offer Insights on Healthcare Companies: Amgen (AMGN), ImmunoGen (IMGN) and Guardant Health (GH)NASDAQ:IMGNImmunoGen Inc
05/23/20226:09AMDow Jones NewsImmunoGen Gets FDA Priority Review of Mirvetuximab Soravtansine in Ovarian CancerNASDAQ:IMGNImmunoGen Inc
05/23/20225:41AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
05/23/20225:30AMBusiness WireImmunoGen Announces Acceptance of Biologics License Application for Mirvetuximab Soravtansine in Ovarian Cancer by US Food and Drug Administration with Priority ReviewNASDAQ:IMGNImmunoGen Inc
05/10/20223:30PMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at Upcoming H.C. Wainwright Global Investment ConferenceNASDAQ:IMGNImmunoGen Inc
05/10/20225:16AMTipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Amicus (FOLD), Azenta (AZTA) and ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
05/09/20226:45AMTipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:IMGNImmunoGen Inc
05/06/202211:36AMTipRanksSVB Securities Keeps Their Hold Rating on ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
05/06/20225:42AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
05/06/20225:30AMBusiness WireImmunoGen Reports Recent Progress and First Quarter 2022 Financial ResultsNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN